Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2018 Apr 3;106(2):521–525. doi: 10.1016/j.athoracsur.2018.02.073

Table 2.

Demographics and Pre-Operative Data of Stentless Aortic Valve Reoperation

Variables N=143

Patient Age (years) 59 (50, 67)
 <50 34 (24)
 50–59 39 (27)
 ≥60 70 (49)
Sex (Female) (%) 27 (19)
Pre-existing Comorbidities
 Diabetes Mellitus 24 (17)
 PAD 13 (9)
 CAD 55 (38.5)
 Myocardial Infarction (<30 days) 8 (6)
 History of Stroke 19 (13)
 History of Smoking 72 (50)
 COPD 21 (15)
 Hypertension 97 (68)
 Pre-op Creatinine (mg/dL) 1 (1, 1)
 Renal Failure on Dialysis 6 (4)
 Pre-operative Atrial Fibrillation 22 (15)
Indications for Reoperation
 Aortic Stenosis 39 (27)
 Patient-Prosthesis Mismatch 0
 Aortic Insufficiency 107 (75)
 Active Endocarditis 46 (32)
 Active Endocarditis with Abscess 19 (13)
Interval Between Operations (years) 9 (5, 12)
NYHA Function Class
 I 20 (14)
 II 47 (33)
 III 55 (38.5)
 IV 21 (15)
Ejection Fraction 60 (53, 65)
 >60% 87 (61)
 40–60% 45 (31.5)
 20–40% 11 (8)
 <20% 0

Data presented as median (25%, 75%) for continuous data and n (%) for categorical data.

Abbreviations: PAD, peripheral arterial disease; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association.

HHS Vulnerability Disclosure